Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohide Tamura

Showing results (71-80 of 263) with videos related to

Pageof 27
Sort By:
Oncology|October 2, 2008
Gender differences in treatment outcomes among patients with non-small cell lung cancer given a combination of carboplatin and paclitaxelHarukaze Yamamoto, Ikuo Sekine, Kazuhiko Yamada, et al.
Biomedical Chromatography : BMC|July 28, 2009
Simple and sensitive HPLC method for determination of amrubicin and amrubicinol in human plasma: application to a clinical pharmacokinetic studyReiko Ando, Yoshinori Makino, Tomohide Tamura, et al.
Cancer|January 19, 2022
A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE-BCKazuo Matsuura, Junji Tsurutani, Kenichi Inoue, et al.
Clinical Lung Cancer|September 5, 2015
Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non-Small-Cell Lung CancerMakoto Nishio, Koichi Goto, Kenichi Chikamori, et al.
BMC Pulmonary Medicine|July 14, 2022
Findings of virtual bronchoscopic navigation can predict the diagnostic rate of primary lung cancer by bronchoscopy in patients with peripheral lung lesionsAtsushi Kitamura, Yutaka Tomishima, Ryosuke Imai, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2009
A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancerNoboru Yamamoto, Tomohide Tamura, Takayasu Kurata, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2018
Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancerMakoto Nishio, Kazuhiko Nakagawa, Tetsuya Mitsudomi, et al.
Carcinogenesis|July 16, 2002
Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1Noriko Yanagitani, Takashi Kohno, Noriaki Sunaga, et al.
Respiratory Investigation|May 16, 2021
Reproducibility of peripheral branches in virtual bronchoscopic navigation using VINCENT and LungPoint software for peripheral lung lesionsAtsushi Kitamura, Kohei Okafuji, Ryosuke Imai, et al.
International Journal of Cancer|December 4, 2003
Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cellsFumiaki Koizumi, Fumihiko Kanzawa, Yutaka Ueda, et al.
Pageof 27

Showing results (71-80 of 263) with videos related to

Sort By:
Pageof 27
Oncology|October 2, 2008
Gender differences in treatment outcomes among patients with non-small cell lung cancer given a combination of carboplatin and paclitaxelHarukaze Yamamoto, Ikuo Sekine, Kazuhiko Yamada, et al.
Biomedical Chromatography : BMC|July 28, 2009
Simple and sensitive HPLC method for determination of amrubicin and amrubicinol in human plasma: application to a clinical pharmacokinetic studyReiko Ando, Yoshinori Makino, Tomohide Tamura, et al.
Cancer|January 19, 2022
A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE-BCKazuo Matsuura, Junji Tsurutani, Kenichi Inoue, et al.
Clinical Lung Cancer|September 5, 2015
Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non-Small-Cell Lung CancerMakoto Nishio, Koichi Goto, Kenichi Chikamori, et al.
BMC Pulmonary Medicine|July 14, 2022
Findings of virtual bronchoscopic navigation can predict the diagnostic rate of primary lung cancer by bronchoscopy in patients with peripheral lung lesionsAtsushi Kitamura, Yutaka Tomishima, Ryosuke Imai, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2009
A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancerNoboru Yamamoto, Tomohide Tamura, Takayasu Kurata, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2018
Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancerMakoto Nishio, Kazuhiko Nakagawa, Tetsuya Mitsudomi, et al.
Carcinogenesis|July 16, 2002
Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1Noriko Yanagitani, Takashi Kohno, Noriaki Sunaga, et al.
Respiratory Investigation|May 16, 2021
Reproducibility of peripheral branches in virtual bronchoscopic navigation using VINCENT and LungPoint software for peripheral lung lesionsAtsushi Kitamura, Kohei Okafuji, Ryosuke Imai, et al.
International Journal of Cancer|December 4, 2003
Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cellsFumiaki Koizumi, Fumihiko Kanzawa, Yutaka Ueda, et al.
Pageof 27